Opioid Use Disorder Market - Global Outlook and Forecast 2022-2028

January 2022 | 70 pages | ID: O1731E58FA37EN
Market Monitor Global

Abstracts

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

This report contains market size and forecasts of Opioid Use Disorder in Global, including the following market information:

Global Opioid Use Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Opioid Use Disorder market was valued at 1798.3 million in 2021 and is projected to reach US$ 2608.2 million by 2028, at a CAGR of 5.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Buprenorphine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Opioid Use Disorder include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus and Omeros. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Use Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Opioid Use Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Opioid Use Disorder Market Segment Percentages, by Type, 2021 (%)

• Buprenorphine
• Methadone
• Naltrexone

Global Opioid Use Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Opioid Use Disorder Market Segment Percentages, by Application, 2021 (%)

• Moderate Pain Treatment
• Severe Pain Treatment

Global Opioid Use Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Opioid Use Disorder Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Opioid Use Disorder revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Opioid Use Disorder revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Indivior
• Alkermes
• Titan Pharmaceuticals
• Hikma Pharmaceuticals
• Teva Pharmaceuticals
• MediciNova
• Orexo
• Camurus
• Omeros

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Opioid Use Disorder Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Opioid Use Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPIOID USE DISORDER OVERALL MARKET SIZE

2.1 Global Opioid Use Disorder Market Size: 2021 VS 2028
2.2 Global Opioid Use Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Opioid Use Disorder Players in Global Market
3.2 Top Global Opioid Use Disorder Companies Ranked by Revenue
3.3 Global Opioid Use Disorder Revenue by Companies
3.4 Top 3 and Top 5 Opioid Use Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opioid Use Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid Use Disorder Players in Global Market
  3.6.1 List of Global Tier 1 Opioid Use Disorder Companies
  3.6.2 List of Global Tier 2 and Tier 3 Opioid Use Disorder Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Opioid Use Disorder Market Size Markets, 2021 & 2028
  4.1.2 Buprenorphine
  4.1.3 Methadone
  4.1.4 Naltrexone
4.2 By Type - Global Opioid Use Disorder Revenue & Forecasts
  4.2.1 By Type - Global Opioid Use Disorder Revenue, 2017-2022
  4.2.2 By Type - Global Opioid Use Disorder Revenue, 2023-2028
  4.2.3 By Type - Global Opioid Use Disorder Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Opioid Use Disorder Market Size, 2021 & 2028
  5.1.2 Moderate Pain Treatment
  5.1.3 Severe Pain Treatment
5.2 By Application - Global Opioid Use Disorder Revenue & Forecasts
  5.2.1 By Application - Global Opioid Use Disorder Revenue, 2017-2022
  5.2.2 By Application - Global Opioid Use Disorder Revenue, 2023-2028
  5.2.3 By Application - Global Opioid Use Disorder Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Opioid Use Disorder Market Size, 2021 & 2028
6.2 By Region - Global Opioid Use Disorder Revenue & Forecasts
  6.2.1 By Region - Global Opioid Use Disorder Revenue, 2017-2022
  6.2.2 By Region - Global Opioid Use Disorder Revenue, 2023-2028
  6.2.3 By Region - Global Opioid Use Disorder Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Opioid Use Disorder Revenue, 2017-2028
  6.3.2 US Opioid Use Disorder Market Size, 2017-2028
  6.3.3 Canada Opioid Use Disorder Market Size, 2017-2028
  6.3.4 Mexico Opioid Use Disorder Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Opioid Use Disorder Revenue, 2017-2028
  6.4.2 Germany Opioid Use Disorder Market Size, 2017-2028
  6.4.3 France Opioid Use Disorder Market Size, 2017-2028
  6.4.4 U.K. Opioid Use Disorder Market Size, 2017-2028
  6.4.5 Italy Opioid Use Disorder Market Size, 2017-2028
  6.4.6 Russia Opioid Use Disorder Market Size, 2017-2028
  6.4.7 Nordic Countries Opioid Use Disorder Market Size, 2017-2028
  6.4.8 Benelux Opioid Use Disorder Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Opioid Use Disorder Revenue, 2017-2028
  6.5.2 China Opioid Use Disorder Market Size, 2017-2028
  6.5.3 Japan Opioid Use Disorder Market Size, 2017-2028
  6.5.4 South Korea Opioid Use Disorder Market Size, 2017-2028
  6.5.5 Southeast Asia Opioid Use Disorder Market Size, 2017-2028
  6.5.6 India Opioid Use Disorder Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Opioid Use Disorder Revenue, 2017-2028
  6.6.2 Brazil Opioid Use Disorder Market Size, 2017-2028
  6.6.3 Argentina Opioid Use Disorder Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Opioid Use Disorder Revenue, 2017-2028
  6.7.2 Turkey Opioid Use Disorder Market Size, 2017-2028
  6.7.3 Israel Opioid Use Disorder Market Size, 2017-2028
  6.7.4 Saudi Arabia Opioid Use Disorder Market Size, 2017-2028
  6.7.5 UAE Opioid Use Disorder Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Indivior
  7.1.1 Indivior Corporate Summary
  7.1.2 Indivior Business Overview
  7.1.3 Indivior Opioid Use Disorder Major Product Offerings
  7.1.4 Indivior Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.1.5 Indivior Key News
7.2 Alkermes
  7.2.1 Alkermes Corporate Summary
  7.2.2 Alkermes Business Overview
  7.2.3 Alkermes Opioid Use Disorder Major Product Offerings
  7.2.4 Alkermes Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.2.5 Alkermes Key News
7.3 Titan Pharmaceuticals
  7.3.1 Titan Pharmaceuticals Corporate Summary
  7.3.2 Titan Pharmaceuticals Business Overview
  7.3.3 Titan Pharmaceuticals Opioid Use Disorder Major Product Offerings
  7.3.4 Titan Pharmaceuticals Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.3.5 Titan Pharmaceuticals Key News
7.4 Hikma Pharmaceuticals
  7.4.1 Hikma Pharmaceuticals Corporate Summary
  7.4.2 Hikma Pharmaceuticals Business Overview
  7.4.3 Hikma Pharmaceuticals Opioid Use Disorder Major Product Offerings
  7.4.4 Hikma Pharmaceuticals Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.4.5 Hikma Pharmaceuticals Key News
7.5 Teva Pharmaceuticals
  7.5.1 Teva Pharmaceuticals Corporate Summary
  7.5.2 Teva Pharmaceuticals Business Overview
  7.5.3 Teva Pharmaceuticals Opioid Use Disorder Major Product Offerings
  7.5.4 Teva Pharmaceuticals Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.5.5 Teva Pharmaceuticals Key News
7.6 MediciNova
  7.6.1 MediciNova Corporate Summary
  7.6.2 MediciNova Business Overview
  7.6.3 MediciNova Opioid Use Disorder Major Product Offerings
  7.6.4 MediciNova Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.6.5 MediciNova Key News
7.7 Orexo
  7.7.1 Orexo Corporate Summary
  7.7.2 Orexo Business Overview
  7.7.3 Orexo Opioid Use Disorder Major Product Offerings
  7.7.4 Orexo Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.7.5 Orexo Key News
7.8 Camurus
  7.8.1 Camurus Corporate Summary
  7.8.2 Camurus Business Overview
  7.8.3 Camurus Opioid Use Disorder Major Product Offerings
  7.8.4 Camurus Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.8.5 Camurus Key News
7.9 Omeros
  7.9.1 Omeros Corporate Summary
  7.9.2 Omeros Business Overview
  7.9.3 Omeros Opioid Use Disorder Major Product Offerings
  7.9.4 Omeros Opioid Use Disorder Revenue in Global Market (2017-2022)
  7.9.5 Omeros Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Opioid Use Disorder Market Opportunities & Trends in Global Market
Table 2. Opioid Use Disorder Market Drivers in Global Market
Table 3. Opioid Use Disorder Market Restraints in Global Market
Table 4. Key Players of Opioid Use Disorder in Global Market
Table 5. Top Opioid Use Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opioid Use Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opioid Use Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opioid Use Disorder Product Type
Table 9. List of Global Tier 1 Opioid Use Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Use Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Use Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opioid Use Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opioid Use Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Opioid Use Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opioid Use Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opioid Use Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Opioid Use Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opioid Use Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opioid Use Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opioid Use Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opioid Use Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opioid Use Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opioid Use Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opioid Use Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opioid Use Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opioid Use Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opioid Use Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opioid Use Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opioid Use Disorder Revenue, (US$, Mn), 2023-2028
Table 30. Indivior Corporate Summary
Table 31. Indivior Opioid Use Disorder Product Offerings
Table 32. Indivior Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 33. Alkermes Corporate Summary
Table 34. Alkermes Opioid Use Disorder Product Offerings
Table 35. Alkermes Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 36. Titan Pharmaceuticals Corporate Summary
Table 37. Titan Pharmaceuticals Opioid Use Disorder Product Offerings
Table 38. Titan Pharmaceuticals Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Hikma Pharmaceuticals Corporate Summary
Table 40. Hikma Pharmaceuticals Opioid Use Disorder Product Offerings
Table 41. Hikma Pharmaceuticals Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceuticals Corporate Summary
Table 43. Teva Pharmaceuticals Opioid Use Disorder Product Offerings
Table 44. Teva Pharmaceuticals Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 45. MediciNova Corporate Summary
Table 46. MediciNova Opioid Use Disorder Product Offerings
Table 47. MediciNova Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 48. Orexo Corporate Summary
Table 49. Orexo Opioid Use Disorder Product Offerings
Table 50. Orexo Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Camurus Corporate Summary
Table 52. Camurus Opioid Use Disorder Product Offerings
Table 53. Camurus Opioid Use Disorder Revenue (US$, Mn), (2017-2022)
Table 54. Omeros Corporate Summary
Table 55. Omeros Opioid Use Disorder Product Offerings
Table 56. Omeros Opioid Use Disorder Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Opioid Use Disorder Segment by Type in 2021
Figure 2. Opioid Use Disorder Segment by Application in 2021
Figure 3. Global Opioid Use Disorder Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Opioid Use Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Use Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid Use Disorder Revenue in 2021
Figure 8. By Type - Global Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 12. US Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 16. Germany Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 24. China Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opioid Use Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opioid Use Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. Indivior Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alkermes Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Titan Pharmaceuticals Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hikma Pharmaceuticals Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceuticals Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MediciNova Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Orexo Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Camurus Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Omeros Opioid Use Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)